Abstract
Levilactobacillus brevis PYN10_6_2, a lactic acid bacterial strain previously isolated from Tenebrio molitor larval feces, possesses the ability to convert zearalenone (ZEN) to α-/β-Zearalenol (α-/β-ZEL). However, the genes involved in the ZEN reduction reaction and the biosafety of this strain remain unknown. In this study, we sequenced, assembled, and annotated the whole genome of L. brevis PYN10_6_2. Genomic sequencing was conducted using short-read sequencing on the Illumina HiSeq X Ten platform and long-read sequencing on the PacBio RS II Single Molecule Real-Time (SMRT) platform. The assembled genome consisted of one circular chromosome, four circular plasmids, with a total size of 2,745,725 bp and a G + C content of 45.52 %. Annotation identified 2,660 coding sequences, 5 rRNAs, 66 tRNAs, and a single CRISPR locus. Average nucleotide identity (ANI) between L. brevis PYN10_6_2 and L. brevis DSM 20054(T) yielded a value of 98.94 %. Further in-depth analysis revealed 182 antibiotic resistance genes, 237 putative virulence genes, 2 prophages, and 10 genomic islands. Additionally, functional annotation through COG and KEGG databases revealed the presence of three genes encoding 3α- and 3β-hydroxysteroid dehydrogenase (3α-/3β-HSD) within the bacterial chromosome. This comprehensive genomic characterization provides valuable insights into the genetic basis of L. brevis PYN10_6_2's ZEN-reducing ability and its biosafety profile.